共 91 条
[1]
Siegel RL(2017)Cancer statistics, 2017 CA Cancer J Clin 67 7-30
[2]
Miller KD(2001)Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma Ann Surg 234 507-517
[3]
Jemal A(1991)Role of radiation after operative palliation in cancer of the proximal bile ducts Am J Surg 161 454-458
[4]
Jarnagin WR(2015)SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma J Clin Oncol 33 2617-2622
[5]
Fong Y(2010)Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer N Engl J Med 362 1273-1281
[6]
DeMatteo RP(2012)Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update Gut 61 1657-1669
[7]
Grove MK(2016)Radiochemotherapy with gemcitabine in unresectable extrahepatic cholangiocarcinoma: long-term results of a phase II study Anticancer Res 36 737-740
[8]
Hermann RE(2002)Limitations of conventional doses of chemoradiation for unresectable biliary cancer Int J Radiat Oncol Biol Phys 53 969-974
[9]
Vogt DP(2014)Concurrent chemoradiotherapy for locally advanced unresectable extrahepatic cholangiocarcinoma: a report of 19 cases Zhejiang Da Xue Xue Bao Yi Xue Ban 43 688-694
[10]
Broughan TA(2013)Impact of radiotherapy in the management of locally advanced extrahepatic cholangiocarcinoma BMC Cancer 13 568-488